$505 Million is the total value of Sio Capital Management, LLC's 89 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SOLY | SOLITON INC | $7,831,000 | -1.8% | 1,025,000 | 0.0% | 1.55% | -33.3% | |
| CHAQU | CHARDAN HEALTHCARE ACQUISITION 2 CORPunit | $4,220,000 | +0.5% | 400,000 | 0.0% | 0.84% | -31.8% | |
| VKTX | VIKING THERAPEUTICS INC | $4,131,000 | -19.3% | 709,780 | 0.0% | 0.82% | -45.2% | |
| LSACU | LIFESCI ACQUISITION CORPunit 03/31/2025 | $2,856,000 | +23.6% | 210,000 | 0.0% | 0.57% | -16.0% | |
| ASLN | ASLAN PHARMACEUTICALS LTDads | $2,616,000 | -5.0% | 1,376,954 | 0.0% | 0.52% | -35.6% | |
| ESPR | ESPERION THERAPEUTICS INC | $2,290,000 | -27.6% | 61,600 | 0.0% | 0.45% | -50.9% | |
| DYAI | DYADIC INTERNATIONAL INC | $1,583,000 | -12.5% | 209,064 | 0.0% | 0.31% | -40.7% | |
| AGLE | AEGLEA BIO THERAPEUTICS INC | $1,497,000 | -23.3% | 211,104 | 0.0% | 0.30% | -48.1% | |
| HROW | HARROW HEALTH INC | $1,334,000 | +7.3% | 238,623 | 0.0% | 0.26% | -27.3% | |
| CBIO | CATALYST BIOSCIENCES INC | $854,000 | -26.8% | 198,714 | 0.0% | 0.17% | -50.3% | |
| IDYA | IDEAYA BIOSCIENCES INC | $691,000 | -11.6% | 55,000 | 0.0% | 0.14% | -39.9% | |
| RAPT | RAPT THERAPEUTICS INC | $460,000 | +10.8% | 14,298 | 0.0% | 0.09% | -24.8% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $460,000 | -27.7% | 38,312 | 0.0% | 0.09% | -51.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.